Croatian
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Trevaclyn (laropiprant / nicotinic acid) - C10AD52

Updated on site: 10-Oct-2017

Naziv lijekaTrevaclyn
ATK šifraC10AD52
Tvarlaropiprant / nicotinic acid
ProizvođačMerck Sharp

Sadržaj članka

TREVACLYN

EPAR summary for the public

This document is a summary of the European Public Assessment Report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the studies performed, to

Leaflet (also part of the EPAR) or contact your doctor or pharmacist. If you want more information on the basis of the CHMP recommendations, read the Scientific D cu sion (also part of the EPAR).

Trevaclyn is a medicine containing two active substances: nicotinic acid (also known as niacin or vitamin B3) and laropiprant. It is available as modified-release tablets. ‘Modified-release’ means that the two active substances are released at different rates from the tablet over a few hours.

hypercholesterolaemia’. Patients with combined mixed dyslipidaemia have high blood levels of ‘bad’ LDL cholesterol and triglycerides (a type of fat), and low levels of ‘good’ HDL cholesterol. Primary hypercholesterolaemia is when the levels of cholesterol in the blood are high. Primary means that the hypercholesterolaemia does not have any identifiable cause.

The medicine can only be obtained with a prescription.

Trevaclyn is normally given together with a statin (the standard medicine used to reduce cholesterol) when the effectivenessMedicinalof a st tin taken alone is inadequate. Trevaclyn is used on its own only in patients who cannot take stati s.

How is Trevaclyn us d?

Komentari

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Pomoć
  • Get it on Google Play
  • O nama
  • Info on site by:

  • Presented by RXed.eu

  • 27558

    popisanih lijekova na recept